Glaxo’s Rotarix: rotavirus vaccine Rotarix is effective against severe gastroenteritis
Glaxo’s Rotarix: rotavirus vaccine Rotarix is effective against severe gastroenteritis
Glaxo’s Rotarix Shows Benefit In Latin American Infants-Study. GlaxoSmithKline PLC’s (GSK) rotavirus vaccine Rotarix is effective against severe gastroenteritis for up to two years when given to infants during their first two years of life, according to a late-stage study published Friday in medical journal The [...]